Obinutuzumab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
| Prices in pharmacies: Instructions Obinutuzumab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Obinutuzumab included in the composition |
Prices in pharmacies |
| Gazyva | 1750€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 54% Ofatumumab
- 49% Blinatumomab
- 49% Inotuzumab ozogamicin
- 45% Amsacrine
- 40% Akalabrutinib
- 40% Nilotinib
- 40% Hexaphosphamide
- 37% Bosutinib
- 36% Imatinib
- 36% Venetoclax
- 36% Tioguanine
- 34% Catumaxomab
- 34% Mercaptopurine
- 34% Elotuzumab
- 34% Tremelimumab
- 34% Pertuzumab
- 33% Prodimin
- 33% Fludarabine
- 33% Paphencyl
- 31% Ipilimumab
- 31% Durvalumab
- 31% Isatuximab
- 30% Daratumumab
- 30% Trastuzumab
- 30% Chlorethylaminouracil
- 28% Ibrutinib
- 28% Avelumab
- 28% Teclistamab
- 28% Prolgolimab
- 27% Dasatinib
- 27% Trastuzumab emtansine
- 27% Pembrolizumab
- 26% Clofarabine
- 26% Lophenalac
- 26% Zanubrutinib
- 25% Mosunetuzumab
- 24% Decitabine
- 24% Dipin
- 23% Nivolumab
- 23% Cytarabine
- 23% Rufocromomycin
- 23% Panitumumab
- 23% Glofitamab
- 22% Pegfilgrastim
- 21% Rituximab
- 20% Ceritinib
- 20% Gefitinib
- 20% Cetuximab
- 20% Drostanolone
- 20% Osimertinib
Learn more about the selection of analogues
▶
- The drug has «Obinutuzumab» 51 analog by action, the most similar - Ofatumumab .
- Medical online service has selected the best substitutes for Obinutuzumab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Obinutuzumab to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.